Ignore Dogecoin: Invest In These Instead

Over the long-haul, there is no question that America’s stock market is the greatest wealth creator. It might take a back seat to certain commodities every now and then, but it has delivered the highest annual return over multiple decades.

However, since cryptocurrencies showed up, they have run circles around the overall market. And meme-based cryptocurrency Dogecoin (CRYPTO:DOGE) has been an especially rising superstar recently.

But instead of putting your money into a subpar digital “asset” like Dogecoin, I would suggest letting it work for you in companies that will make you rich. The following two stocks have great catalysts coming soon and all the tools to make you a richer investor.

Intuitive Surgical

Robotic-assisted surgical systems creator Intuitive Surgical (NASDAQ:ISRG) is priced at $800 but don’t let that fool you, it can still give a lot more upside.

Since its start, the company has installed 6,142 of its products worldwide. This might not seem like much, but it is a lot more than its competitors even when combined. The firm’s innovation, the training for surgeons using their systems, and their high product price, make it very likely that these 6,100+ clients will stay loyal.

Intuitive Surgical is also gearing up to expand its operating margins long-term. Whereas its revenue in the 2000s consisted of selling its da Vinci systems, the majority of the company’s sales now come from selling instruments with every procedure, as well as doing maintenance and servicing its products. These are much higher margin sectors, which is great for the company to grow at a faster pace.

Jushi Holdings

The continued legalization of marijuana is an open road for multistate operator Jushi Holdings (JUSHF) to grow. For right now, Jushi is a small company. After completing the purchase of two California dispensaries, it now has 18 dispensaries.

What’s note worthy about their strategy is that the company predominantly focuses on limited-license markets.

Around 80% of Jushi’s 2021 sales will potentially come from the three states of Pennsylvania, Virginia and Illinois. With Virginia giving retail licenses according to jurisdiction, and the other two limiting license issuance.

The point is this: Jushi will have low or zero competition, which will benefit the company in building up its reach and developing a loyal following.

Jushi also has not been hesitant to put its money to work in the buying department to further its growth. It’s done deals in Virginia and Pennsylvania to increase its presence, and as I said, has gone into California, the biggest marijuana market ever.

With Jushi only being three times projected sales, it might be the best buy of the cannabis industry right now.

Author: Steven Sinclaire